TRex Bio, Inc.

TRXB

priced

Analyst-verified

TRex Bio, Inc. is a clinical-stage biopharmaceutical company focused on tissue Treg biology for the discovery and development of immunoregulatory medicines designed to restore immune balance and promote tissue repair to address unmet needs of patients with autoimmune and inflammatory diseases.

Offering

View source filing

Exchange: Nasdaq
Analyst-verified
Price: $14.00
Source: Finnhub
Shares offered: 8,333,334
Source: Finnhub
Expected date: TBD
Priced date: 2026-10-09
Source: Finnhub
Industry: Biopharmaceutical
AI-extracted
Revenue: —
Net income: —

Underwriters

Not yet disclosed.

Filings

S-1/A 2026-10-05View on EDGAR

Track TRXB

Get alerts on new filings and ask our AI analyst about this company.

Research this company